Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Tax Provisions (2022 - 2025)

Historic Tax Provisions for GeneDx Holdings (WGS) over the last 4 years, with Q3 2025 value amounting to $247000.0.

  • GeneDx Holdings' Tax Provisions rose 62553.19% to $247000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $424000.0, marking a year-over-year increase of 15593.67%. This contributed to the annual value of -$343000.0 for FY2024, which is 6295.9% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Tax Provisions is $247000.0, which was up 62553.19% from -$246000.0 recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Tax Provisions peaked at $447000.0 during Q1 2025, and registered a low of -$49.1 million during Q2 2022.
  • For the 4-year period, GeneDx Holdings' Tax Provisions averaged around -$3.6 million, with its median value being -$123500.0 (2023).
  • In the last 5 years, GeneDx Holdings' Tax Provisions crashed by 107857.14% in 2023 and then skyrocketed by 62553.19% in 2025.
  • Over the past 4 years, GeneDx Holdings' Tax Provisions (Quarter) stood at $42000.0 in 2022, then tumbled by 1078.57% to -$411000.0 in 2023, then soared by 94.16% to -$24000.0 in 2024, then skyrocketed by 1129.17% to $247000.0 in 2025.
  • Its last three reported values are $247000.0 in Q3 2025, -$246000.0 for Q2 2025, and $447000.0 during Q1 2025.